LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Symptomatic Respiratory Pathogen Found in Transplant Recipients

By LabMedica International staff writers
Posted on 13 Feb 2019
Image: Microsporidian spores stained Calcofluor White M2R (Photo courtesy of Institute Pasteur of Tunis).
Image: Microsporidian spores stained Calcofluor White M2R (Photo courtesy of Institute Pasteur of Tunis).
As opportunistic pathogens, microsporidia cause symptomatic infections mainly in patients with impaired immune function; and microsporidial dissemination to the central nervous system, eyes, and respiratory and urinary tracts has been documented in these patients.

Iatrogenically immunosuppressed patients, especially transplant recipients, are the group at highest risk of such opportunistic infections, and their dissemination is due to life-long immunosuppressive treatment. Nevertheless, routine differential diagnosis of these pathogens is not performed and little is known about the prevalence of microsporidia in this group of patients.

Infectious disease scientists from the Wroclaw Medical University (Wroclaw, Poland) obtained sputum samples and bronchial washings (BW) from 72 renal transplant recipients and 105 patients with various respiratory diseases were screened for Encephalitozoon spp. and Enterocytozoon bieneusi by microscopic examination and genus-specific nested polymerase chain reaction (PCR) followed by genotyping.

The standard Calcofluor M2R staining method was used to detect microsporidial spores. Sputum and BW samples were homogenized by bead disruption with a Precellys24 Instrument, followed by digestion with proteinase K at 56 °C for 1 hour. A genus-specific nested PCR protocol was used to amplify the partial sequence of the 16S rRNA gene, the entire ITS (internal transcribed spacer) region, and a partial sequence of the 5.8S rRNA gene of E. bieneusi and Encephalitozoon spp. PCR products were sequenced in both directions using the Sanger sequencing method. Amplification and sequencing of each sample was repeated twice.

The investigators reported that a total of 8.3% (6/72) of immunosuppressed renal transplant recipients and 1.9% (2/105) of patients with various respiratory diseases, both immunocompetent and immunosuppressed, were positive for respiratory microsporidial infection. All six transplant recipients were Encephalitozoon cuniculi-positive by PCR/sequencing and five of them suffered from respiratory symptoms. The presence of microsporidial spores was also confirmed microscopically in three of the transplant recipients. Of the two immunocompetent patients with various respiratory diseases, one had an E. cuniculi infection, while the second had an E. bieneusi infection.

The authors concluded that the higher prevalence of E. cuniculi observed among patients after kidney transplantation testifies to the fact that life-long immunosuppression increases the risk of respiratory microsporidial infection in these patients. It is necessary to constantly monitor them, since symptoms of respiratory microsporidiosis are generally undistinguishable from those caused by more common infective agents. Moreover, when infection is untreated, it may lead to acute respiratory failure, which is life threatening for the patient. The study was published in the February 2019 issue of the International Journal of Infectious Diseases.

Related Links:
Wroclaw Medical University

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Capillary Blood Collection Tube
IMPROMINI M3

Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more